Midfacial granuloma syndrome or an inflammatory non-specific disease? A case report

Journal of Oral Pathology and Medicine

Volumn 30, Issue 3, 2001, Pages 190-192

  Torre, Valerio ^a   Bucolo, Sebastiano ^a   Galletti, Bruno ^a   Cavallari, Vittorio ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Idiopathic midline syndrome; Midface granuloma; Nasal biopsy

Indexed keywords

ANTIINFLAMMATORY AGENT; CD3 ANTIGEN; PREDNISONE;

ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MIDLINE GRANULOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; T LYMPHOCYTE;

ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD3; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; GRANULOMA, LETHAL MIDLINE; HUMANS; MALE; MIDDLE AGED; PREDNISONE; T-LYMPHOCYTES;

EID: 0035125539     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2001.300310.x     Document Type: Article

References (8)

1. On classification of changes in necrotizing lesions of the midface
2. Dilemmas in the management of chronic nasal and sinus inflammatory diseases of unknown etiology
3. Midfacial necrotizing lesions
4. Granulomatous lesions in nasal biopsies
5. Idiopathic midline destructive disease (IMDD): A subgroup of patients with the "midline granuloma" syndrome
6. Nasal T-cell lymphoma as a differential diagnosis of the midline granuloma syndrome
7. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing
8. Chemotactic activity of neutrophil granulocytes in old people in health or with symptoms of infection